Subchapter 18D - Pituitary Adenylate Cyclase-Activating Polypeptide-Related Peptide
-
Add time:09/06/2019 Source:sciencedirect.com
Pituitary adenylate cyclase-activating polypeptide-related peptide (PRP), also named GHRH-like peptide, was identified as a structurally related peptide of PACAP on the PACAP precursor. PRP and PRP-like peptides were identified in vertebrates and tunicates. Mammalian PRP peptides are 29 aa residues in length, non-mammalian PRP peptides 43–46 aa, and tunicate PRP-like peptides 27 aa. PRP/PACAP precursor is detected most abundantly in the central nervous tissues, especially in the hypothalamus. The PRP receptor, formerly referred to as the GHRH receptor, is a G protein-coupled receptor with a seven transmembrane helical domain. Although a receptor highly specific for PRP has been characterized in non-mammals, a specific receptor for PRP has not been isolated in any mammalian species. PRP receptor mRNA was widely detected in brain, pituitary, and peripheral tissues. PRP has potential to stimulate GH release from anterior pituitary cells, but the potency is lower in the chicken and lost in mammals.
We also recommend Trading Suppliers and Manufacturers of PITUITARY ADENYLATE CYCLASE ACTIVATING (cas 136134-68-4). Pls Click Website Link as below: cas 136134-68-4 suppliers
Prev:Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) in the regulation of hypothalamic kisspeptin expression☆
Next:Chapter 18 - Secretin (Pituitary Adenylate Cyclase-Activating Polypeptide) Family) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Chapter 18 - Secretin (Pituitary Adenylate Cyclase-Activating Polypeptide) Family09/07/2019
- Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) in the regulation of hypothalamic kisspeptin expression☆09/05/2019
- Subchapter 18C - Pituitary Adenylate Cyclase-Activating Polypeptide09/04/2019
- Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships09/03/2019
- Full Length ArticleProtective effects of PITUITARY ADENYLATE CYCLASE ACTIVATING (cas 136134-68-4) polypeptide against neurotoxic agents09/02/2019
- Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor09/01/2019
- Pituitary adenylate cyclase-activating polypeptide: Postnatal development in multiple brain stem respiratory-related nuclei in the rat08/31/2019
- Distribution of pituitary adenylate cyclase-activating polypeptide 2 in zebrafish brain08/30/2019
- Emerging evidence for the role of pituitary adenylate cyclase-activating peptide in neuropsychiatric disorders08/29/2019


